Requip™
Develop once-daily formulation of Requip® (ropinerol) for SmithKline Beecham
- Second major project for SB
- Treatment for Parkinson’s disease
- Receive royalties and technology access fee
- Full responsibility for clinical trials
- Reimbursed through milestone payments
SB takes $8 million equity stake in SkyePharma, but total project much bigger